Michael DePetrillo

Scientist at Jaguar Gene Therapy

Michael DePetrillo has worked as a Scientist at Jaguar Gene Therapy since October 2022. Prior to that, they served as an Analytical Development Specialist at Medicago from December 2014 to October 2022. From October 2006 to April 2007, they worked as a Laboratory Technician at BARC. Michael also worked as a Technical IRTA at the National Institutes of Health from February 2003 to June 2004.

Michael DePetrillo has a diverse educational background. Michael began their education at Union College from 1997 to 1999, where they studied Biology, General. Michael then transferred to Hamilton College, where they completed their Bachelor of Arts (BA) degree in Biochemistry from 1999 to 2003. Continuing their education, DePetrillo pursued a Master's degree in Human Nutrition at The Johns Hopkins University from 2004 to 2006. Lastly, they attended the University of North Carolina at Chapel Hill from 2007 to 2013, specializing in Nutritional Biochemistry.

Location

Durham, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Jaguar Gene Therapy

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. Led by the former AveXis leadership team and backed by Deerfield Management, a healthcare-specific investment firm, Jaguar brings streamlined R&D, manufacturing and clinical operations to accelerate development and potential approval of therapies for severe genetic diseases.


Industries

Employees

51-200

Links